Evolus (EOLS) Current Assets (2017 - 2026)
Evolus (EOLS) posted Current Assets of $138.9 million for Q1 2026, down 2.79% on a QoQ basis from $142.9 million in Q4 2025, and up 5.47% year-over-year from $131.7 million in Q1 2025.
Evolus (EOLS) Current Assets (2017 - 2026) Analysis & Trends
Evolus' Current Assets history runs 10 years deep, the most recent figure standing at $138.9 million for Q1 2026.
- Quarterly Current Assets rose 5.47% year-over-year to $138.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $138.9 million (up 5.47% YoY) and the FY2025 annual result came in at $142.9 million, down 5.57% from the prior year.
- Current Assets was $138.9 million for Q1 2026 at Evolus, down from $142.9 million in the prior quarter.
- Across five years, Current Assets topped out at $158.1 million in Q2 2024 and bottomed at $84.1 million in Q1 2023.
- A 5-year average of $128.4 million and a median of $134.9 million in 2025 frame the typical range for Current Assets.
- Peak annual rise in Current Assets reached 83.91% in 2022, while the deepest fall reached 43.62% in 2022.
- Evolus' Current Assets stood at $100.8 million in 2022, then advanced by 11.53% to $112.4 million in 2023, then surged by 34.62% to $151.3 million in 2024, then dropped by 5.57% to $142.9 million in 2025, then retreated by 2.79% to $138.9 million in 2026.
- Business Quant data shows EOLS's Current Assets at $138.9 million in Q1 2026, $142.9 million in Q4 2025, and $134.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | 138.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 138.92 Mn |
| Dec 31, 2025 | 142.92 Mn |
| Sep 30, 2025 | 134.89 Mn |
| Jun 30, 2025 | 144.97 Mn |
| Mar 31, 2025 | 131.72 Mn |
| Dec 31, 2024 | 151.34 Mn |
| Sep 30, 2024 | 150.36 Mn |
| Jun 30, 2024 | 158.13 Mn |
| Mar 31, 2024 | 150.27 Mn |
| Dec 31, 2023 | 112.42 Mn |
| Sep 30, 2023 | 92.00 Mn |
| Jun 30, 2023 | 96.46 Mn |
| Mar 31, 2023 | 84.09 Mn |
| Dec 31, 2022 | 100.80 Mn |
| Sep 30, 2022 | 115.95 Mn |
| Jun 30, 2022 | 133.95 Mn |
| Mar 31, 2022 | 142.93 Mn |
| Dec 31, 2021 | 178.80 Mn |
| Sep 30, 2021 | 138.34 Mn |
| Jun 30, 2021 | 161.89 Mn |